{"transactions":[{"id":2118329,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122453,"kind":"person","name":"Arkhipenko Anatoli","position":1,"cik":"0001924934","reported_name":"Arkhipenko Anatoli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-11-14T10:02:00.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":68737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest on the first day of every calendar quarter following January 1, 2023 (with the first tranche to vest on April 1, 2023), with any remaining unvested RSUs to vest on January 1, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":111754,"source":{"system":"sec-edgar","filing":"0001779128-22-000118","document":"wf-form4_166843807685193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924934/000177912822000118/wf-form4_166843807685193.xml","form_type":"4"}},{"id":2245292,"issuer":{"id":5512,"kind":"organization","name":"Strata Critical Medical, Inc.","symbol":"SRTA"},"owners":[{"id":122453,"kind":"person","name":"Arkhipenko Anatoli","position":1,"cik":"0001924934","reported_name":"Arkhipenko Anatoli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Class A common stock, $0.0001 par value per share","published_at":"2022-06-03T16:01:16.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":43017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\"), which will be settled in shares of the Issuer's common stock upon vesting. The RSUs will vest over 48 months, with 25% (rounded down to the nearest whole number) vesting on April 11, 2023, and 6.25% (rounded down to the nearest whole number) vesting every three months following April 11, 2023, with any remainder to vest on April 11, 2026, such that 100% will be vested on April 11, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":43017,"source":{"system":"sec-edgar","filing":"0001924934-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924934/000192493422000004/primary_doc.xml","form_type":"4"}}]}